Life Sciences Tools and Services
Company Overview of Agilux Laboratories, Inc.
Agilux Laboratories, Inc., a contract research organization, offers a range of services supporting discovery, pre-clinical, and clinical services. It provides a range of drug metabolism and pharmacokinetic (DMPK) Services for biotech and pharmaceutical industries. The company’s services include discovery bioanalytical, GLP bioanalytical, in vivo, in vitro, and Immunoassays (biomarkers) services. Agilux Laboratories was founded in 2007 and is based in Worcester, Massachusetts.
One Innovation Drive
Worcester, MA 01605
Founded in 2007
Key Executives for Agilux Laboratories, Inc.
Co-Founder, Chief Executive Officer and President
Co-Founder and Vice President of Sales & Marketing
Senior Director of Operations and IT
Head of GLP Bioanalysis - Pharmaceutical Development Services
Compensation as of Fiscal Year 2015.
Agilux Laboratories, Inc. Key Developments
Agilux Laboratories, Inc. Adds MDCK/MDCK-MDR1 Assays to its Suite of ADMET in Vitro Assay Services
Dec 17 15
Agilux Laboratories, Inc. announced that it is now offering MDCK/MDCK-MDR1 assays, in addition to the existing Caco-2 assays, for assessing the membrane permeability properties of early drug discovery compounds. These permeability assays are part of their extensive suite of ADMET in vitro assay services. Caco-2 assays are used to predict intestinal absorption and also potential efflux by transporters, including P-glycoprotein (Pgp). Likewise, MDCK cells transfected with human MDR1 (Pgp) are useful for assessing candidate compounds for potential as a Pgp substrate or inhibitor, as well as blood-brain-barrier penetration. These assays have been extensively evaluated and qualified to assure their optimum performance and reliability.
Agilux Laboratories, Inc. Appoints Richard M. LeLacheur as Head of GLP Bioanalysis for Bioanalytical Operations
Apr 9 14
Agilux Laboratories, Inc. announced that it has appointed Richard M. LeLacheur, Ph.D. to Head of GLP Bioanalysis for its pharmaceutical development services. Rich joined Agilux in early 2012 as Senior Director, Bioanalytical Operations and has also served as a member of its senior management team since that time. In his new role, Rich will be directly responsible for driving the scientific, regulatory and operational processes and improvements within its GLP bioanalytical labs.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries